Skip to content
POM-VPS Prescription Required

Premadex 0.8mg/ml Oral Solution for Sheep

Active ingredient: Ivermectin

Form

Liquid

Species

Sheep

Manufacturer

Chanelle Pharmaceuticals Manufacturing Ltd

VMD MA No.

08749/4029

What it's used for

For the treatment of infections with the following parasites: Nematodes Gastrointestinal roundworms (adult and fourth larval stage) Haemonchus contortus Te...

Full indications, dosage and side effects ↓
View official SPC (PDF)

The prescription itself has a price. See what practices near you charge for a consultation and the written prescription fee.

Paying less for Ivermectin

  1. 1

    Ask your vet for a written prescription

    They must provide one on request. Under the CMA Order the fee is capped at £21 from 2027.

  2. 2

    Fill it at a registered online retailer

    The CMA found online pharmacies 50–60% cheaper than practice dispensing on common medicines — typically £200–£300 a year.

Prescription required

Your vet must provide a written prescription on request. You can then purchase from any licensed online retailer.

Clinical information

Premadex 0.8mg/ml Oral Solution for Sheep — SPC Details

Source: VMD Summary of Product Characteristics (SPC). Last updated 26 Mar 2026.

For the treatment of infections with the following parasites:
Nematodes
Gastrointestinal roundworms (adult and fourth larval stage)
Haemonchus contortus
Teladorsagia circumcincta
Trichostrongylus spp.
Cooperia spp.
Nematodirus spp.
Including N. battus
Strongyloides papillosus
Chabertia ovina
Lungworms (adult and fourth larval stage)
Dictyocaulus filaria
Arthropods

Revised: June 2018
AN: 02171/2017
Nasal bot (all larval stages)
Oestrus ovis
For oral administration only.
The recommended dose rate is 0.2 mg ivermectin per kg bodyweight
(corresponding to 2.5 ml per 10 kg bodyweight)
To ensure administration of a correct dose, body weight should be
determined as accurately as possible. Accuracy of the dosing device
should be checked.
If animals are to be treated collectively rather than individually they
should be grouped according to their bodyweight and dosed
accordingly, in order to avoid under- or over- dosing.
Do not use in animals with known hypersensitivity to the active
ingredient or any of the excipients.
Some sheep may cough immediately after treatment. This passing
response is of no consequence.
Care should be taken to avoid the following practices because they
increase the risk of development of resistance and could ultimately
result in ineffective therapy:
•
class, over an extended period of time.
•
weight or misadministration of the product.
Resistance to ivermectin (an avermectin) has been reported in
Teladorsagia
Haemonchus in sheep outside the EU. Therefore the use of this product
should be based on local (regional, farm) epidemiological information
about susceptibility of nematode and recommendations on how to limit
further selection for resistance to anthelmintics.
Suspected clinical cases of resistance to anthelmintics should be further
investigated using appropriate tests (e.g. Faecal Egg Count Reduction
Test). Where the results of the test(s) strongly suggest resistance to a
particular anthelmintic, an anthelmintic belonging to another
pharmacological class and having a different mode of action should be
used.
There is cross-resistance with other avermectins and with milbemycins

(i)Special precautions for use in animals
The timing of treatment should be based on epidemiological factors and
should be customised for each individual farm. A dosing programme
should be established by the veterinary surgeon.
Veterinary advice should be sought on appropriate dosing programmes
and stock management to achieve adequate parasite control, and to
reduce the likelihood of anthelmintic resistance developing. Veterinary
advice should also be sought if the product does not achieve the
desired clinical effect, as other diseases, nutritional disturbances or
anthelmintic resistance might be involved'.
Avermectins may not be well tolerated in non-target species. Cases of
intolerance resulting in fatalities have been reported in dogs, especially
Collies, Old English Sheep Dogs and related breeds or crosses, and
also in turtles/tortoises.

Revised: June 2018
AN: 02171/2017
(ii) Special precautions to be taken by the person administering
the veterinary medicinal product to animals
Wash hands after use. Avoid contact with skin and eyes.
Do not eat, drink or smoke while handling the product.
Wear impervious gloves when handling or administering the product.
As absorption through skin can occur, in the event of accidental skin
contact, wash the affected area immediately with soap and water.
If accidental eye exposure occurs, flush the eyes immediately with
water.
(iii) Other precautions
None known.
interaction
None known.
Do not store above 30ºC.
interaction
None known.
4.9 Amounts to be administered and administration route
For oral administration only.
The recommended dose rate is 0.2 mg ivermectin per kg bodyweight
(corresponding to 2.5 ml per 10 kg bodyweight)
To ensure administration of a correct dose, body weight should be
determined as accurately as possible. Accuracy of the dosing device
should be checked.
If animals are to be treated collectively rather than individually they
should be grouped according to their bodyweight and dosed
accordingly, in order to avoid under- or over- dosing.
4.10 Overdose (symptoms, emergency procedures, antidotes), if
necessary

Revised: June 2018
AN: 02171/2017
At doses up to 4 mg ivermectin per kg administered by stomach tube
(20x the recommended dose level) undesirable toxic reactions
occurred. Acute symptoms (ataxia, staggering gait, incoordination,
depression) were observed at the dose rate of 8 mg/kg (40x the
recommended dose level) during a study carried out on 4 animals.
Twenty-four hours later, the animals showed only mild incoordination
and depression.
Three days post dose all the animals were nearly normal. It is possible
that the signs of toxaemia were due to the propylene glycol.
No antidote has been identified. Symptomatic treatment may be
beneficial.
4.11 Withdrawal period(s)
Meat and offal: 10 days.
Milk: Do not use in lactating sheep producing milk for human
consumption.
Sheep must not be treated within 60 days prior to the commencement
of lactation, if milk is to be used for human consumption.
5.

This information is sourced from the official Summary of Product Characteristics (SPC) published by the Veterinary Medicines Directorate (VMD). It is provided for informational purposes only and does not replace professional veterinary advice. Always consult your vet before administering any medication.

Medication costs adding up?

Pet insurance can cover prescription medications. Find the right policy for your pet.

Compare insurance

Find cheaper vets near you

Compare vet consultation prices in your area. Save on procedures and get a prescription to buy medications online.